EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY-NC 4.0

Influenza-Triggered Seronegative Myasthenia Gravis in an Anaplastic Lymphoma Kinase-Positive Lung Cancer Patient on Chronic Alectinib: A Case Report

Michael Motoc, Sand Mastrangelo, Sruthi Valluri, Carrie J Li, Edison K Miyawaki

Case Reports in Neurology · 09.06.2026 · 18 (1) · 370-379

DOI: 10.1159/000552849 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Case Reports in Neurology, online erschienen am 09.06.2026. Verfasst von Michael Motoc und 4 weiteren Autor:innen. Beteiligte Einrichtung: Harvard Medical School, Boston, MA, USA. Die Arbeit nennt 12 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Seronegative myasthenia gravis is an under-recognized cause of acute neuromuscular respiratory failure, and its convergence with infection and targeted oncologic therapy, specifically anaplastic lymphoma kinase inhibition, is poorly characterized, underscoring the importance of vigilance in oncologic patients presenting with respiratory failure. Case Presentation: A 51-year-old man with anaplastic lymphoma kinase-positive non-small-cell lung cancer on long-term alectinib presented with fever, cough, and progressive generalized weakness. He tested positive for influenza A and rapidly developed respiratory failure requiring intubation. Neurological examination demonstrated ptosis, oculobulbar involvement, and proximal weakness. Repetitive nerve stimulation showed a decremental response, while assays for acetylcholine receptor, anti-muscle-specific kinase, and anti-lipoprotein receptor-related protein 4 antibodies were negative. A diagnosis of seronegative myasthenia gravis was established. The patient received intravenous immunoglobulin, plasma exchange, pyridostigmine, corticosteroids, and azathioprine with gradual clinical improvement.

Conclusion

Early recognition of myasthenia gravis in this population is critical to initiate appropriate immunotherapy and supportive management. This case illustrates the difficulty of distinguishing underlying disease and treatment-related effects from new-onset neurological syndromes. It highlights the importance of neurological considerations in cases of progressive respiratory difficulty and posits a putative link between chronic immunosuppression and subsequent susceptibility to autoimmune insult, as well as the need for more aggressive treatment in the setting of immunosuppression.

Schlagwörter

Stichwörter der Autor:innen

AlectinibAnaplastic lymphoma kinase-positiveInfluenzaNon-small-cell lung cancerSeronegative myasthenia gravis

Autor:innen und Institutionen

  • Harvard Medical School, Boston, MA, USA.
  • Department of Psychiatry, Mass General Brigham, Brigham and Women's Hospital, Boston, MA, USA.
  • Department of Medicine, Mass General Brigham, Brigham and Women's Hospital, Boston, MA, USA.
  • Department of Neurology, Mass General Brigham, Brigham and Women's Hospital, Boston, MA, USA.

Zitieren

APA

Motoc, M., Mastrangelo, S., Valluri, S., Li, C. J., & Miyawaki, E. K. (2026). Influenza-Triggered Seronegative Myasthenia Gravis in an Anaplastic Lymphoma Kinase-Positive Lung Cancer Patient on Chronic Alectinib: A Case Report. Case Reports in Neurology, 18(1), 370-379. https://doi.org/10.1159/000552849

Vancouver

Motoc M, Mastrangelo S, Valluri S, Li CJ, Miyawaki EK. Influenza-Triggered Seronegative Myasthenia Gravis in an Anaplastic Lymphoma Kinase-Positive Lung Cancer Patient on Chronic Alectinib: A Case Report. Case Reports in Neurology. 2026;18(1):370-379. doi:10.1159/000552849

BibTeX
@article{Motoc2026,
  author = {Motoc, Michael and Mastrangelo, Sand and Valluri, Sruthi and Li, Carrie J and Miyawaki, Edison K},
  title = {Influenza-Triggered Seronegative Myasthenia Gravis in an Anaplastic Lymphoma Kinase-Positive Lung Cancer Patient on Chronic Alectinib: A Case Report},
  journal = {Case Reports in Neurology},
  year = {2026},
  volume = {18},
  number = {1},
  pages = {370--379},
  doi = {10.1159/000552849}
}
Kostenlos starten →